Keith Speights

Keith Speights

TMFFishBiz

Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.

Recent articles

Hands holding lighted world

3 Game-Changing Stocks to Buy and Hold for the Next 20 Years

These companies are likely to be a lot bigger in 2040 -- and make patient investors a ton of money along the way.


Woman with smartphone and dollar signs

If You Invested $10,000 in Livongo Health's IPO, This Is How Much Money You'd Have Now

The digital health stock has been a big winner.


Man holding small globe with a mask and money

3 Top Coronavirus Stocks to Buy in October

Their coronavirus programs are only part of the attraction for these stocks.


2020 and 2030 with a ladder

Where Will Moderna Be in 10 Years?

Probably a lot bigger than it is now.


Gloved hand holding coronavirus vaccine bottle

Better Coronavirus Stock: Johnson & Johnson vs. Novavax

These COVID-19 vaccine leaders offer very different risk-reward propositions.

Small cap stocks

How Many Small-Cap Stocks Are There?

The number changes quickly.


Test tubes

Why Precigen Stock Is Skyrocketing Today

A big partner is increasing its stake in the biopharmaceutical company.


Scientist with syringe and vaccine bottle

Is BioNTech a Better Coronavirus Stock to Buy Than Its Big Partner Pfizer?

Here's how the two COVID-19 vaccine partners stack up against each other.


Woman holding book with light bulb and money

Investing $1,000 in These 3 Stocks Would Be a Really Smart Move Right Now

These stocks are in great shape to deliver strong growth over the long run.


Woman - telehealth visit

Is This Sizzling IPO Stock Getting Too Hot to Handle?

AmWell is riding high after its IPO last month. Can it keep the momentum going?

Scientists looking through microscopes

Why Cardiff Oncology Stock Skyrocketed Today

An analyst's bullish outlook sent the biotech stock soaring.


Cannabis with chart going up

Why Aphria, Curaleaf, and Several Other Cannabis Stocks Are Flying Higher Today

Investors appear to be increasingly optimistic about the prospects for marijuana legalization in the U.S. after two developments on Wednesday.


Woman with 3 lines going up

3 Popular Robinhood Stocks That Could Realistically Double Within 1 Year

Here's what it would take.


Businessman holding umbrella over coins

3 Safe Stocks to Buy in a Not-So-Safe Market

These stocks are well-positioned whether turbulent times come or not.


Scientist holding coronavirus

Why Sorrento Therapeutics Stock Jumped Today

The biotech provided two encouraging updates.

Cannabis plants

Why GrowGeneration Stock Is Jumping Today

A short squeeze just might be under way.


Coronavirus with money

3 Reasons to Buy the Most Popular Coronavirus Stock on Robinhood

The stock might not be a surprise. But at least one of the reasons to buy it probably will be.


Shadow of dollar sign on cannabis pile

7 Million More Reasons to Stay Away From Aurora Cannabis Stock

Actually, it's closer to 7.4 million reasons.


Injecting COVID-19 vaccine into globe

AstraZeneca's Coronavirus Vaccine Is Already Being Reviewed for Approval in Canada and Europe. Why Not in the U.S.?

This one-time Operation Warp Speed favorite isn't even moving at a snail's speed in America.


Man looking at money bags with dollar signs and question marks

Is Inovio a Bad-News Buy?

There's still a chance that the biotech could have some good news on the way.